Brighter carries out a directed share issue of SEK 35.4 M.

Brighter’s Board of Directors has, with authorization from the Annual General Meeting on May 9, 2019, decided to carry out a directed share issue to strengthen the company’s balance sheet. The share issue, totalling SEK 35.4 million, is made through cash payment and will be partly used to repay loans.

After this, the balance sheet will be completely cleared of interest-bearing loans. Remaining in the balance sheet will only be loans attributed to Winance and these do not bear interest. The purpose of the share issue and the reason for the deviation from the shareholders' preferential rights is to strengthen the company's balance sheet in a time- and capital-efficient manner.

The subscription price is set at SEK 10.13. This is considered reasonable as it corresponds to approximately a 10% discount on the share price on September 3.

The number of shares in the company increases by 3,494,355 to a total of 89,828,246. The share capital increases by SEK 174,717.75 to a total of SEK 4,491,412.30.

For further information, please contact:

Henrik Norström, CEO   
Phone: +46 733 40 30 45      
Email: henrik.norstrom@brighter.se

Ann Zetterberg, CFO
Phone: +46 708 37 21 23
E-mail: ann.zetterberg@brighter.se

About Brighter AB (publ).
Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare’s biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop®- is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their close associates, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. https://brighter.se/ 

The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 00, info@eminova.se, www.eminova.se.

This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 18:30 CET on September 5, 2019.

About Us

Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of the most serious healthcare problems: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop™ - is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and close associates, healthcare providers, research, pharmaceutical industry and society. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. https://brighter.se/ The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser is Eminova Fondkommission AB +46 (0)8 – 684 211 00, info@eminova.se, www.eminova.se

Subscribe

Documents & Links